The Globe and Mail reports in its Tuesday, June 6, edition that Echelon Capital analyst Rob Goff is sticking with his "buy" call on Converge Technology Solutions. The Globe's David Leeder writes that Mr. Goff trimmed his share target by a loonie to $6. He believes the shares are "undervalued." Analysts on average target the shares at $5.71. Mr. Goff expects Converge shares will be under negative pressure ahead of its removal from the S&P/TSX 300 Composite on June 19. Mr. Goff, however, continues to see "underlying fundamental value in the shares where forecasts balance improved supply-chain conditions with economic caution." Mr. Goff says in a note: "We look for pressure around the TSX Index removal and where the NCIB buying completes the program. We would view pressure on the shares as a positive window given our fundamental view. We could see continued demand strength with Q223 results and the announcement of an SIB potentially together with the sale or sell-down of its stake in Portage as positive catalysts. While imprecise, we estimate this move would impact roughly nine million shares of Converge. The net impact must further factor short positions in the market ahead of its removal."